Sabordo, Baby Boy .

HRN: 27-27-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/23/2025
06/29/2025
IV
30mg
OD
Psnb
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: